Found 25 matching trials
: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors PHASE1 This is a phase Ib/II study to evaluate the safety, tolerability, PK profil...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer N/A The survival of the refractory CRC is dismal and therapy options are limite...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases PHASE2 Colorectal cancer (CRC) is a significant cause of morbidity and mortality w...
Show More Learn More & Join Trial
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma PHASE2 The goal of this prospective, interventional clinical trial is to evaluatio...
Show More Learn More & Join Trial
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma PHASE2 This was a single-arm, prospective study to investigate the efficacy and sa...
Show More Location
Wuhan Union Hospital, China
Learn More & Join Trial
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage PHASE2 A single-arm, phase II study was designed to evaluate the efficacy and safe...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer PHASE2 This study is a single-arm, open-label, single-center clinical trial design...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors PHASE1 This study aims to evaluate the efficacy of CVL218 in combination with Tori...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) PHASE2 The study consists of two parts, the first part is a randomized, open-label...
Show More Status
Active Not Recruiting
Location
Beijing Chao-Yang Hospital, Capital Medical University
Learn More & Join Trial
The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer PHASE2 Colorectal cancer is a malignant tumor ranking among the top four in incide...
Show More Location
Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, Zhejiang Province 310999
Learn More & Join Trial